#1523 Two cases of hyperacute rejection after AB0 incompatible kidney transplantation – unexpected antibodies
Notice bibliographique
Résumé
Abstract Background and Aims Although ABO-incompatible (ABOi) living donor kidney transplantation is currently performed on a routine basis, it remains a procedure with a high immunologic risk requiring both immunosuppression aimed at diminishing antibody production and removal of circulating antibodies from the recipient's blood. Method We describe two cases of kidney transplant recipients (KTR) who experienced hyperacute antibody-mediated rejection after ABOi transplantation and further testing was performed on their sera using a novel bead-based ABO antibody assay to understand the cause of such unfortunate outcomes. Results Both patients were ABO-O recipients who received ABO-A grafts; neither had donor-specific anti-HLA antibodies (DSA). Both received rituximab >4 weeks and standard immunosuppression according to the Swiss ABOi protocol, starting 10–25 days before transplantation; basiliximab was used for induction at time of transplant. Immunoadsorption was performed before transplant with a nonselective Therasorb column; immunoadsorption effectiveness was analyzed by measuring the anti-A-IgG titer and anti-A-IgM titer by gel column agglutination technique. Case 1: Transplantation was performed after 17 immunoadsorption runs (prolonged due to postponed date of surgery for non-immunological reasons); post-adsorption anti-A titres were negative IgG and <1:8 IgM. After an initial diuresis, the patient became anuric within 24 hours. Biopsy histology revealed hyperacute rejection. Graft nephrectomy was performed two days post-transplant. Case 2: transplantation was performed after 11 immunoadsorption runs; post-adsorption anti-A titres were negative IgG and 1:1 IgM. After an initial diuresis urine output decreased within hours. Biopsy histology showed hyperacute rejection. Plasmapheresis was started empirically approximately 15 hours after transplant despite negative anti-A titer and no anti-HLA DSA, and treatment with high dose steroids, IVIG and eculizumab was administered. Graft nephrectomy was performed seven days post-transplant. Analysis of the original sera with a novel single antigen bead assay for anti-A subtype-specific antibodies showed an initial drop in MFIs of IgG and IgM for both patients. However, at time of transplant, despite acceptable anti-A titers with our standard hemagglutination methods, patient 1 and 2 MFI were still 17200 and 9300, respectively for anti-A-IgG isotype antibodies (II, III and IV averaged) and 3300 and 3800 for anti-A-IgM isotype IgM (II, III and IV averaged). Analysis of sera from the days immediately after transplantation showed a rebound for these subtype-specific anti-A antibodies in Case 1, with an MFI up to 26000 (anti-A-IgG) and 5000 (anti-A-IgM). In Case 2 (where samples were drawn after plasmapheresis) the MFIs of the anti-A-II/III/IV further dropped to 2100 (IgG) and 1200 (IgM). Refer to Fig. 1 for antibody data. Conclusion Hyperacute AMR in these two ABO-A-incompatible kidney transplant cases was likely due to insufficient removal of anti-A antibodies. Whether this is due to insufficient removal of anti-A antibodies by the nonselective Therasorb column needs to be further investigated. These results suggest that for such an immunological high-risk procedure, a switch from titer-based diagnostics to single bead Luminex diagnostics should be considered. Of further note, transcriptome diagnostics might support the histology, but it is not yet established in ABOi graft biopsies.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,001 | 0,004 |
| Méta-épidémiologie (sens strict) | 0,003 | 0,001 |
| Méta-épidémiologie (sens large) | 0,001 | 0,002 |
| Bibliométrie | 0,003 | 0,002 |
| Études des sciences et des technologies | 0,002 | 0,002 |
| Communication savante | 0,002 | 0,002 |
| Science ouverte | 0,002 | 0,002 |
| Intégrité de la recherche | 0,006 | 0,003 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,004 | 0,002 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».